digoxigenin (Digoxin) antibody and antigen (hapten, BSA/OVA conjugated)
Diagnostic anti-digoxigenin (Digoxin) antibodies (anti-digoxigenin, anti-Digoxin) and diagnostic hapten-carrier conjugates BSA-digoxigenin (Digoxin), OVA-digoxigenin (Digoxin), KLH-digoxigenin (Digoxin) antigens for Cardiovascular disease Digoxin detection in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-SMT-Digoxin-Ag01 | BSA-digoxigenin (Digoxin) | 756 |
GMP-SMT-Digoxin-Ag02 | OVA-digoxigenin (Digoxin) | 756 |
GMP-SMT-Digoxin-Ab01 | Anti-human digoxigenin (Digoxin) mouse monoclonal antibody (mAb) | 1953 |
GMP-SMT-Digoxin-Ab02 | Anti-human digoxigenin (Digoxin) human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-SMT-Digoxin-Ag01 |
Product Name | BSA-digoxigenin (Digoxin) |
Target/Biomarker | digoxigenin (Digoxin) |
Expression platform | Synthetic |
Isotypes | NA |
Bioactivity validation | digoxigenin (Digoxin) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Digoxin level test of Cardiovascular disease () and related syndrome evaluation. |
Tag | NA |
Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-digoxigenin (Digoxin) / OVA-digoxigenin (Digoxin) is Synthetic. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-SMT-Digoxin-Ag02 |
Product Name | OVA-digoxigenin (Digoxin) |
Target/Biomarker | digoxigenin (Digoxin) |
Expression platform | Synthetic |
Isotypes | NA |
Bioactivity validation | digoxigenin (Digoxin) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Digoxin level test of Cardiovascular disease () and related syndrome evaluation. |
Tag | NA |
Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-digoxigenin (Digoxin) / OVA-digoxigenin (Digoxin) is Synthetic. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-SMT-Digoxin-Ab01 |
Product Name | Anti-human digoxigenin (Digoxin) mouse monoclonal antibody (mAb) |
Target/Biomarker | digoxigenin (Digoxin) |
Expression platform | Hybridoma |
Isotypes | Mouse IgG |
Bioactivity validation | digoxigenin (Digoxin) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Digoxin level test of Cardiovascular disease () and related syndrome evaluation. |
Tag | mFc |
Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-digoxigenin (Digoxin) / OVA-digoxigenin (Digoxin) is Synthetic. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-SMT-Digoxin-Ab02 |
Product Name | Anti-human digoxigenin (Digoxin) human monoclonal antibody (mAb) |
Target/Biomarker | digoxigenin (Digoxin) |
Expression platform | Hybridoma |
Isotypes | Mouse IgG |
Bioactivity validation | digoxigenin (Digoxin) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Digoxin level test of Cardiovascular disease () and related syndrome evaluation. |
Tag | mFc |
Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-digoxigenin (Digoxin) / OVA-digoxigenin (Digoxin) is Synthetic. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Digoxin, sold under the brand name Lanoxin among others, is a medication used to treat various heart conditions.[4] Most frequently it is used for atrial fibrillation, atrial flutter, and heart failure.[4] Digoxin is one of the oldest medications used in the field of cardiology.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.